Another round of drug recalls has been issued by the FDA, naming common blood pressure and heart failure medications containing losartan, valsartan and irbesartan. The recalls are due to impurities from N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), as well as NDMA and NDEA, which are classified as a potential human carcinogen.
The FDA says the investigation has already identified thousands of tainted drugs and more are likely to be discovered by safety authorities.
The U.S. Food and Drug Administration noted in a news release that Camber Pharmaceuticals Inc. has thus far recalled 87 lots of losartan tablets. The recalled tablets were manufactured by Hetero Labs Ltd. in India and distributed by Camber Pharmaceuticals. Camber has not received any reports of adverse events related to the recalled drugs, though cancer risks are clearly a concern.
The Camber Pharmaceutical recall is only the latest in a huge investigation into the entire class of drugs known as angiotensin receptor blockers (ARBs), which contain either valsartan, losartan or irbesartan.
Joe Lyon is a highly-rated Cincinnati, Ohio product liability attorney and Losartan lawyer investigating Losartan recall lawsuits and cancer risks for plaintiffs nationwide.
The Lyon Firm has experience engaging pharmaceutical companies following recalls and pharmaceutical negligence.
Beginning in July 2018, several lots of ARB blood pressure and heart failure medications manufactured with losartan, valsartan and irbesartan from various companies were recalled for containing traces of potential human carcinogens, including N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA).
The current FDA analyses of NDMA and NDEA note a low risk for developing cancer, though any added risk is reason enough for a recall and losartan recall lawsuits targeting several drug makers including the following:
ABOUT THE LYON FIRM
Joseph Lyon has 17 years of experience representing individuals in complex litigation matters. He has represented individuals in every state against many of the largest companies in the world.
The Firm focuses on single-event civil cases and class actions involving corporate neglect & fraud, toxic exposure, product defects & recalls, medical malpractice, and invasion of privacy.
NO COST UNLESS WE WIN
The Firm offers contingency fees, advancing all costs of the litigation, and accepting the full financial risk, allowing our clients full access to the legal system while reducing the financial stress while they focus on their healthcare and financial needs.
NDMA, or N-nitrosodimethylamine, has been classified as a “probable carcinogen” by the FDA. NDMA has no approved uses in the United States, and the chemicals NDEA and NBMA also have carcinogenic properties. Toxicologists agree the dose and duration of NDMA exposure determines if a Valsartan patient’s cancer can be attributed to the contaminated drug.
Some patients will have consumed enough NDMA in contaminated Valsartan and Losartan that their risk for certain cancers like digestive tract cancers, liver cancer, kidney cancer, stomach cancer, and colorectal cancer rises dramatically.
Not all ARB products are contaminated or contain NDMA, NDEA or NMBA impurities, so patients should ask their doctor about an alternative medication unaffected by the Losartan and Valsartan recalls.
The U.S. Food and Drug Administration (FDA) has reported that it is continuing its investigation and product liability attorneys are filing Losartan recall lawsuits to hold companies liable for their negligence.
Contact a Valsartan Cancer Lawyer if:
The FDA has expressed concerns over Valsartan’s and Losartan’s “genotoxic impurities,” which can cause harm at trace levels. When consumers and patients are harmed by contaminated medications due to the negligence of drug companies, the companies can be held liable for the disregard of consumer health.
If you have been diagnosed with liver cancer, kidney cancer, stomach cancer, intestinal cancer or colon cancer, contact a Losartan lawyer to review your particular case and pending class action lawsuits.
Camber Pharma and other manufacturers have a duty to mind the well-being of consumers, and should they fail to do so, they may face losartan recall lawsuits, personal injury and product liability claims.
By taking the initiative and filing drug injury lawsuits, plaintiffs can receive proper compensation and hold a corporation accountable for their negligent actions. Consumer safety depends largely on making sure companies operate within the law and within ethical boundaries.
When drug makers and large corporations are negligent and produce dangerous products that lead to cancer, serious illness and injury, legal action can be necessary. In the current corporate environment, filing lawsuits is one of the only ways to keep drug companies from selling untested and dubious pharmaceuticals in the name of profit.
Pharmaceutical litigation – through a lawsuit against a drug manufacturer – helps bring awareness to these companies as to the necessary changes that need to occur in order to keep people safe a healthy while taking a certain drug.
By taking the initiative and filing a Losartan injury lawsuit, plaintiffs can receive proper compensation and hold a corporation accountable for their negligent actions. Consumer safety depends largely on making sure companies operate within the law and within ethical boundaries.
Always check with your doctor before continuing to take a drug hat has been recalled. There are some lots of Losartan that have been contaminated and may lead to illness or cancer.
Cancers that have been linked to taking valsartan, losartan and irbesartan may include: Liver cancer. Stomach cancer. Pancreatic cancer.
Most people understand what a class action lawsuit is, and fewer are aware of what an MDL refers to. It is important for a claimant to know, however, that an MDL is not a class action, as the term is often misapplied in this context, and the original court (home or transferee jurisdiction) retains the authority to present the case at trial.
In most MDL settings, the case is resolved by way of settlement or a summary judgment motion on the questions of science (i.e., Daubert Motion). If either settlement or dismissal on Motion occurs, the case is not remanded to the originating court. If the case is not resolved at the MDL, then the case may be remanded to original jurisdiction for additional discovery on the case specifics and ultimately trial.
Yes, several lots of the drug, as well as valsartan-containing drugs have been recalled.
Speak to your doctor about other drug options if you are concerned with Losartan contamination. Telmisartan is one option, which has similar coverage to losartan. Telmisartan and olmesartan may be just as effective at lowering blood pressure.
The Lyon Firm has the experience, resources and dedication to take on difficult and emotional Losartan Cancer cases and help our clients obtain the justice for the wrong they have suffered.
Experience: Joe Lyon is an experienced Cincinnati Pharmaceutical Lawyer. The Lyon Firm has 17 years of experience and success representing individuals and plaintiffs in all fifty states, and in a variety of complex civil litigation matters. Pharmaceutical lawsuits can be complex and require industry experts to determine the root cause of an accident or injury. Mr. Lyon has worked with experts nationwide to assist individuals understand why an injury occurred and what can be done to improve their lives in the future. Some cases may go to a jury trial, though many others can be settled out of court.
The Lyon Firm aggressively, professionally, and passionately advocates for injured individuals and families against drug companies due to pharmaceutical injury to obtain just compensation under the law.
This pharmaceutical case involved claims that the blockbuster painkiller was causing heart attacks and strokes in consumers. The FDA ultimately recalled the medication. Merck settled the outstanding Vioxx claims for $4.85 billion following multiple trials in both state and federal courts. Joe Lyon was co-counsel in a number of individual claims that were successfully resolved in the federal MDL. The funds received for Lyon Firm clients helped several elderly clients with additional medical and home health care.
A pharmaceutical case involving claims that a popular surgical medication was causing kidney failure and death. The FDA recalled the medication in question, but not before thousands of patients died due to related complications. Bayer resolved certain claims for $60 Million for patients who suffered kidney failure and death as a result of using the drug Trasylol. Joseph Lyon represented a widow from Kentucky whose husband died due to kidney failure following the administration of Trasylol. The recovered funds assisted the surviving family members in resuming farming operations.